The Okuda staging system was the first classification system to combine tumor sizes, measures of liver function, bilirubin levels, serum albumin, and tumor size with patients classified as either stage I (not advanced), stage II (moderately advanced), or stage III (very advanced) [18]. Here, ALB is linked to neoplasm.